TTM
27.4%
YoY change
+5.43pp
Trough year (2001)
7.5%
Peak year (2025)
27.2%
Latest annual
27.2%
Net Profit Margin history chart for ResMed (RMD) from 1993 to 2025
Latest: 27.2%
Net Profit Margin change chart for ResMed (RMD) from 1993 to 2025
Latest: +5.43pp
Net Profit Margin history table for ResMed (RMD) from 1993 to 2025
| 2025 | 27.2% | +5.43pp | ||
| 2024 | 21.8% | +0.54pp | ||
| 2023 | 21.3% | -0.53pp | ||
| 2022 | 21.8% | +6.94pp | ||
| 2021 | 14.8% | -6.18pp | ||
| 2020 | 21.0% | +5.50pp | ||
| 2019 | 15.5% | +2.04pp | ||
| 2018 | 13.5% | -3.08pp | ||
| 2017 | 16.6% | -2.60pp | ||
| 2016 | 19.2% | -1.85pp | ||
| 2015 | 21.0% | -1.19pp | ||
| 2014 | 22.2% | +1.92pp | ||
| 2013 | 20.3% | +1.66pp | ||
| 2012 | 18.6% | +0.36pp | ||
| 2011 | 18.3% | +0.86pp | ||
| 2010 | 17.4% | +1.50pp | ||
| 2009 | 15.9% | +2.70pp | ||
| 2008 | 13.2% | +3.95pp | ||
| 2007 | 9.3% | -5.28pp | ||
| 2006 | 14.5% | -0.69pp | ||
| 2005 | 15.2% | -1.66pp | ||
| 2004 | 16.9% | +0.17pp | ||
| 2003 | 16.7% | -1.66pp | ||
| 2002 | 18.4% | +10.88pp | ||
| 2001 | 7.5% | -11.73pp | ||
| 2000 | 19.2% | +1.05pp | ||
| 1999 | 18.2% | +2.23pp | ||
| 1998 | 15.9% | +0.70pp | ||
| 1997 | 15.2% | +2.24pp | ||
| 1996 | 13.0% | +1.09pp | ||
| 1995 | 11.9% | +3.28pp | ||
| 1994 | 8.6% | -1.76pp | ||
| 1993 | 10.4% | — |
- 202527.2%+5.43pp
- 202421.8%+0.54pp
- 202321.3%-0.53pp
- 202221.8%+6.94pp
- 202114.8%-6.18pp
- 202021.0%+5.50pp
- 201915.5%+2.04pp
- 201813.5%-3.08pp
- 201716.6%-2.60pp
- 201619.2%-1.85pp
- 201521.0%-1.19pp
- 201422.2%+1.92pp
- 201320.3%+1.66pp
- 201218.6%+0.36pp
- 201118.3%+0.86pp
- 201017.4%+1.50pp
- 200915.9%+2.70pp
- 200813.2%+3.95pp
- 20079.3%-5.28pp
- 200614.5%-0.69pp
- 200515.2%-1.66pp
- 200416.9%+0.17pp
- 200316.7%-1.66pp
- 200218.4%+10.88pp
- 20017.5%-11.73pp
- 200019.2%+1.05pp
- 199918.2%+2.23pp
- 199815.9%+0.70pp
- 199715.2%+2.24pp
- 199613.0%+1.09pp
- 199511.9%+3.28pp
- 19948.6%-1.76pp
- 199310.4%—
Net Profit Margin values are taken from ResMed's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Net Profit Margin at ResMed (RMD)
According to ResMed's latest reported financial statements, the company's latest reported net margin is 27.4%. Net profit margin is net income divided by revenue — the bottom-line share of each sales dollar that remains after all costs, including operating expenses, interest, and taxes. It is the most comprehensive profitability ratio, though it can swing on one-off items, so read it alongside the multi-year trend below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, ResMed (RMD) reported net margin of 27.22% – expanded 5.4 percentage points year-over-year.
2025 marks the peak net margin at 27.22%, with the historical low of 7.50% recorded in 2001.
ResMed Net Profit Margin by Year
ResMed Net Profit Margin 2025: 27.2%
2025's net margin for ResMed came in at 27.22%, expanded 5.4 percentage points from 2024. This figure represents the highest annual value in the available history.
ResMed Net Profit Margin 2024: 21.8%
ResMed posted net margin of 21.79% in 2024, expanded 0.5 percentage points from 2023.
ResMed Net Profit Margin 2023: 21.3%
In 2023, ResMed reported net margin of 21.25%, contracted 0.5 percentage points from 2022.
ResMed Net Profit Margin 2022: 21.8%
ResMed net margin in 2022 was 21.78%, expanded 6.9 percentage points from 2021.
ResMed Net Profit Margin 2021: 14.8%
ResMed net margin in 2021 was 14.84%.
See more financial history for ResMed (RMD).
Sector peers by Net Profit Margin
Healthcare peers of ResMed (RMD), ranked by their latest net margin
| 37.2% | |
| 35.0% | |
| 21.4% | |
| 20.9% | |
| 17.2% | |
| 13.6% | |
| 5.8% | |
| 2.7% |
- 37.2%
- 35.0%
- 20.9%
- 17.2%
- 13.6%
- 5.8%
Frequently asked questions
ResMed (RMD) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation